SAS-1 is a C2 domain protein critical for centriole integrity in C. elegans

PLoS Genet. 2014 Nov 20;10(11):e1004777. doi: 10.1371/journal.pgen.1004777. eCollection 2014 Nov.

Abstract

Centrioles are microtubule-based organelles important for the formation of cilia, flagella and centrosomes. Despite progress in understanding the underlying assembly mechanisms, how centriole integrity is ensured is incompletely understood, including in sperm cells, where such integrity is particularly critical. We identified C. elegans sas-1 in a genetic screen as a locus required for bipolar spindle assembly in the early embryo. Our analysis reveals that sperm-derived sas-1 mutant centrioles lose their integrity shortly after fertilization, and that a related defect occurs when maternal sas-1 function is lacking. We establish that sas-1 encodes a C2 domain containing protein that localizes to centrioles in C. elegans, and which can bind and stabilize microtubules when expressed in human cells. Moreover, we uncover that SAS-1 is related to C2CD3, a protein required for complete centriole formation in human cells and affected in a type of oral-facial-digital (OFD) syndrome.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Caenorhabditis elegans / genetics*
  • Caenorhabditis elegans / growth & development
  • Cell Line
  • Centrioles / genetics*
  • Centrioles / metabolism
  • Centrosome / metabolism
  • Cilia / genetics
  • Cilia / physiology
  • Embryo, Nonmammalian
  • Flagella / genetics
  • Flagella / physiology
  • Gene Expression Regulation, Developmental
  • Humans
  • Male
  • Microtubule-Associated Proteins / biosynthesis
  • Microtubule-Associated Proteins / genetics*
  • Microtubules / genetics
  • Microtubules / metabolism*
  • Spermatozoa / growth & development
  • Spermatozoa / metabolism

Substances

  • C2cd3 protein, human
  • Microtubule-Associated Proteins

Grants and funding

This work was supported by a doctoral fellowship from the Boehringer Ingelheim Fonds to LvT, by post-doctoral fellowships from EMBO (ALTF 237-2007) and from the Human Frontiers Science Program (LT01017/2008-L) to TMD, by post-doctoral fellowships from EMBO (ALTF 98-2001) and the Roche Research Foundation (161-2004) to MD, as well as a grant from the ERC to PG (AdG 233335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.